Leukemia

Papers
(The H4-Index of Leukemia is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Quantifying measurable residual disease correctly2366
The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH)2081
MCL1 as a therapeutic vulnerability in Burkitt lymphoma182
Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis173
CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL159
Cohesin mutations in acute myeloid leukemia143
Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia141
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial129
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis125
Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core120
Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia120
Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15105
Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study103
Clonal medicine targeting DNA damage response eradicates leukemia99
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age94
Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradication93
The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim–Chester disease in adults92
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation91
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia88
Rheumatoid arthritis and the risk of hematologic malignancies: a nationwide cohort study87
Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide82
Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders81
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms81
Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma77
Real-time genomic characterization of pediatric acute leukemia using adaptive sampling76
An MDM2 degrader for treatment of acute leukemias73
Nucleic acid therapeutics as differentiation agents for myeloid leukemias72
Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma72
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma69
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia69
Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial69
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase68
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments66
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)65
Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms64
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)64
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche64
Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 200964
DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cells64
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries63
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation62
Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells61
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation60
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 959
Real life evaluation of AlphaMissense predictions in hematological malignancies58
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial57
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies55
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia54
Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation54
Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia54
RNAseqCNV: analysis of large-scale copy number variations from RNA-seq data53
Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions51
0.057058095932007